ImmunityBio, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2016 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
ImmunityBio, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2016 to Q3 2024.
- ImmunityBio, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $500K, unchanged year-over-year.
- ImmunityBio, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $2M, a 5.26% increase year-over-year.
- ImmunityBio, Inc. annual Amortization of Intangible Assets for 2023 was $2M, a 5.26% increase from 2022.
- ImmunityBio, Inc. annual Amortization of Intangible Assets for 2022 was $1.9M.
- ImmunityBio, Inc. annual Amortization of Intangible Assets for 2019 was $600K, a 73.9% decline from 2018.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)